Saturday, January 31, 2026

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

North Korea Opens Beach Resort, but Tourists May Not Come

North Korea's new coastal resort aims to attract Russian and potentially Chinese tourists, but experts warn broader outreach is needed for success.

$100M Offers? OpenAI Staff Said ‘No Thanks’ to Meta’s Big Money

Sam Altman reveals Meta's failed attempts to recruit OpenAI talent despite offers of up to $100 million, highlighting corporate culture issues.

Tag: SRBM

No posts to display

Top News

- Our Sponsors Ad -

Follow us